Basic Aspects -- Molecular Diagnostics in Personalized Medicine -- Role of Biomarkers in Personalized Medicine -- Pharmacogenetics -- Pharmacogenomics -- Pharmacoproteomics.-Â{u2BEC}e of Metabolomics in Personalized Medicine -- Non-genomic Factors in the Development of Personalized Medicine -- Personalized Biological Therapies -- Personalized Therapy of Cancer -- Personalized Management of Infectious Diseases -- Personalized Management of Neurological Disorders -- Personalized Management of Psychiatric Disorders -- Personalized Management of Cardiovascular Disorders -- Personalized Management of Pulmonary Disorders -- Personalized Management of Genetic Disorders -- Personalized Approaches to Immune Disorders -- Personalized Approaches to Miscellaneous Problems in Healthcare.-Â{u0972}sonalized Non-Pharmacological Therapies -- Development of Personalized Medicine.-Â{u5D28}hical Aspects of Personalized Medicine -- Regulatory Aspects of Personalized Medicine.-Â{u58EF}onomics of Personalized Medicine -- Future of Personalized Medicine.

Advances in the technology used in personalized medicine and increased applications for clinical use have created a need for this expansion and revision of Kewal K. Jainâ€{u3814}extbook of Personalized Medicine. As the first definitive work on this topic,Â{u4A29}s bookÂ{u2976}iews the fundamentals and development of personalized medicine and subsequent adoptions of the concepts by the biopharmaceutical industry and the medical profession. It also discusses examples of applications in key therapeutic areas, as well as ethical and regulatory issues, providing a concise and comprehensive source of reference for those involved in healthcare management, planning, and politics. Algorithms are included as a guide to those involved in the management of important diseases where decision-making is involved due to the multiple choices available. Textbook of Personalized Medicine, Second Edition will serve as a convenient source of information for physicians, scientists, decision makers in the biopharmaceutical and healthcare industries, and interested members of the public.